Iterum Therapeutics(ITRM)

1.29 -0.03 -2.2727%

今开:1.33昨收:1.32
最高:1.35 最低:1.2602
涨停价:0.0跌停价:0.0
总市值:2.1355802E7

Iterum Therapeutics的热门讨论

当期报告

Iterum Therapeutics(ITRM)03-29 19:25

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-038414  Act: 34  Size: 424 KB 网页链接查看全文

当期报告

Iterum Therapeutics(ITRM)05-11 04:25

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 5.02 and 8.01 Accession Number: 0000950170-24-057831  Act: 34  Size: 153 KB 网页链接查看全文

其他

Iterum Therapeutics(ITRM)04-26 19:35

$Iterum Therapeutics(ITRM)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-048655  Act: 34  Size: 4 MB 网页链接查看全文

当期报告

Iterum Therapeutics(ITRM)05-13 19:25

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-058190  Act: 34  Size: 305 KB 网页链接查看全文

当期报告

Iterum Therapeutics(ITRM)03-06 21:25

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-026878  Act: 34  Size: 188 KB 网页链接查看全文

当期报告

Iterum Therapeutics(ITRM)04-30 04:35

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-049928  Act: 34  Size: 178 KB 网页链接查看全文

年度财报

Iterum Therapeutics(ITRM)03-28 19:35

$Iterum Therapeutics(ITRM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-037615  Act: 34  Size: 17 MB 网页链接查看全文

当期报告

Iterum Therapeutics(ITRM)04-06 04:35

$Iterum Therapeutics(ITRM)$ 8-K Current report, item 3.01 Accession Number: 0000950170-24-042288  Act: 34  Size: 156 KB 网页链接查看全文

其他

Iterum Therapeutics(ITRM)04-26 19:25

$Iterum Therapeutics(ITRM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-048651  Act: 34  Size: 2 MB 网页链接查看全文

季度财报

Iterum Therapeutics(ITRM)05-13 19:35

$Iterum Therapeutics(ITRM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-058200  Act: 34  Size: 10 MB 网页链接查看全文

1 2

Iterum Therapeutics的最新讨论

LAES1682021-06-16 21:07

$Citius(CTXR)$ 开始疯狂了,不贪,100%利润,sold all。目前有四个风险,第一疯涨后技术面回调,第二数据不好,腰斩。第三数据不全,要求补充,20%回调,第四数据好可能发新股。itrm确实性高一些,下月直接到FDA环节了,还可以逢低关注。$Iterum Therapeutics(ITRM)$ $纳斯达克100指数(.NDX)$ @今...查看全文

LAES1682021-06-15 00:45

$Iterum Therapeutics(ITRM)$ 先出一半,留下利润,本周大盘在议息会议和四巫日可能调整。$Citius(CTXR)$ $恐慌1.5X做多-ProShares(UVXY)$查看全文

LAES1682021-05-28 12:02

$Iterum Therapeutics(ITRM)$ Regulatory ContextAdvisory Committee meetings are not required in order for a product to be approved. In fact, an AgencyIQ analysis{AgencyIQ analysis} showed that only 88 of 357 new drug approvals...查看全文

LAES1682021-05-28 11:16

$Iterum Therapeutics(ITRM)$ This is a double-edged sword. On the one hand, if your novel drug has promising efficacy and safety data, then not having to make the case before an advisory committee meeting saves considerable effort and time. On the other hand, if your product d...查看全文

LAES1682021-05-24 21:52

$Iterum Therapeutics(ITRM)$ 底部区域,加仓查看全文

LAES1682021-05-20 02:43

$Iterum Therapeutics(ITRM)$ 重新上车,抗耐药抗生素即将获批查看全文

晚安海绵宝宝2021-02-19 19:01

$Iterum Therapeutics(ITRM)$明早接回来看看 100股.观察一下查看全文

有为的股价小宝石2021-02-13 07:23

$Iterum Therapeutics(ITRM)$ 不玩了,ra和sarrisa都跑了[滴汗]查看全文

1 2 3 4 5

Iterum Therapeutics的公告

季度财报

$Iterum Therapeutics(ITRM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-058200  Act: 34  Size: 10 MB 网页链接

当期报告

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-058190  Act: 34  Size: 305 KB 网页链接

当期报告

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 5.02 and 8.01 Accession Number: 0000950170-24-057831  Act: 34  Size: 153 KB 网页链接

当期报告

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-049928  Act: 34  Size: 178 KB 网页链接

其他

$Iterum Therapeutics(ITRM)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-048655  Act: 34  Size: 4 MB 网页链接

其他

$Iterum Therapeutics(ITRM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-048651  Act: 34  Size: 2 MB 网页链接

股东委托书协议

$Iterum Therapeutics(ITRM)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-048646  Act: 34  Size: 3 MB 网页链接

当期报告

$Iterum Therapeutics(ITRM)$ 8-K Current report, item 3.01 Accession Number: 0000950170-24-042288  Act: 34  Size: 156 KB 网页链接

当期报告

$Iterum Therapeutics(ITRM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-038414  Act: 34  Size: 424 KB 网页链接

年度财报

$Iterum Therapeutics(ITRM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-037615  Act: 34  Size: 17 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33